BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35716171)

  • 21. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
    Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
    Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
    Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior fossa lateral ependymoma in childhood.
    Nagib MG; O'Fallon MT
    Pediatr Neurosurg; 1996 Jun; 24(6):299-305. PubMed ID: 8988495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of chemotherapy in newly diagnosed ependymoma of childhood.
    Souweidane MM; Bouffet E; Finlay J
    Pediatr Neurosurg; 1998 May; 28(5):273-8. PubMed ID: 9732262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pediatric ependymomas: Current diagnosis and therapy].
    Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
    Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
    Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
    J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.
    Massimino M; Giangaspero F; Garrè ML; Genitori L; Perilongo G; Collini P; Riva D; Valentini L; Scarzello G; Poggi G; Spreafico F; Peretta P; Mascarin M; Modena P; Sozzi G; Bedini N; Biassoni V; Urgesi A; Balestrini MR; Finocchiaro G; Sandri A; Gandola L;
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1440-5. PubMed ID: 16863927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the management of adult ependymomas with emphasis on relapsed disease.
    Iqbal MS; Lewis J
    Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):726-33. PubMed ID: 23972764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children.
    Liu AK; Foreman NK; Gaspar LE; Trinidad E; Handler MH
    Pediatr Blood Cancer; 2009 Jul; 52(7):804-7. PubMed ID: 19260098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Management of Pediatric Ependymomas.
    Lin FY; Chintagumpala M
    Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group.
    Garvin JH; Selch MT; Holmes E; Berger MS; Finlay JL; Flannery A; Goldwein JW; Packer RJ; Rorke-Adams LB; Shiminski-Maher T; Sposto R; Stanley P; Tannous R; Pollack IF;
    Pediatr Blood Cancer; 2012 Dec; 59(7):1183-9. PubMed ID: 22949057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after first relapse of childhood intracranial ependymoma.
    Tsai JW; Manoharan N; Alexandrescu S; Zimmerman MA; Scully J; Chordas C; Clymer J; Wright KD; Filbin M; Ullrich NJ; Marcus KJ; Haas-Kogan D; Chi SN; Bandopadhayay P; Yeo KK
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28930. PubMed ID: 33565268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes following proton therapy for pediatric ependymoma.
    Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
    Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
    Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.
    Lassaletta A; Perez-Olleros P; Scaglione C; Sirvent S; De Prada I; Perez-Martinez A; Ruiz-Hernandez A; Madero L
    J Neurooncol; 2007 Jul; 83(3):303-6. PubMed ID: 17245619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
    Dorfer C; Tonn J; Rutka JT
    Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy.
    Merchant TE; Haida T; Wang MH; Finlay JL; Leibel SA
    J Neurosurg; 1997 Jun; 86(6):943-9. PubMed ID: 9171172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.